Clinical Trial

Physiological Parameters in CRPS Patients Treated With Dorsal Root Ganglion Stimulation

Study acronym: EPIC-DRG
Completed
View on ClinicalTrials.gov →
Summary
1. Objective and Rationale: The study seeks to evaluate how Dorsal Root Ganglion Stimulation (DRGS) influences autonomic functions in patients suffering from Complex Regional Pain Syndrome type I (CRPS I), offering new metrics beyond pain scores to assess therapeutic efficacy. 2. Innovative Approach: Continuous monitoring of patients using validated, CE-marked biosensors (Corsano Biosensor and Motionwatch8) to collect real-time physiological data during active DRGS therapy and therapy cessation periods. 3. Clinical Impact: Results from this study may improve patient management strategies and refine treatment protocols for individuals living with CRPS I.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-26.
Status change: Active, Not Recruiting → Completed 2026-04-23
Trial Details
NCT Number NCT07147140
Lead Sponsor AZ Delta
Collaborators: Vrije Universiteit Brussel
Conditions CRPS (Complex Regional Pain Syndrome) Type I
Enrollment 24 participants
Start Date 2025-09-08
Primary Completion 2026-02-24 (estimated)
Study Completion 2026-02-24 (estimated)
Updated on ClinicalTrials.gov 2026-04-24